Health Care
| Fractional Tumor Burden Mapping Enhances GBM Trial | 13-Nov-2025 | 11:24 | RNS |
| IB Announces Completion of Phase 1 Trial of GaM | 10-Nov-2025 | 15:14 | RNS |
| Further Re: Purchase of interest in Kirkstall Ltd | 16-Oct-2025 | 07:00 | RNS |
| Purchase of Kirkstall and CLN - Correction | 14-Oct-2025 | 12:15 | RNS |
| Purchase of Kirkstall and CLN with Truetide plc | 14-Oct-2025 | 07:00 | RNS |
| Vivan Therapeutics and IB Announce Partnership | 03-Oct-2025 | 12:16 | RNS |
| IB Enters Agreement with MedImageMetric | 16-Sep-2025 | 15:49 | RNS |
| Half-year Report | 13-Aug-2025 | 11:48 | RNS |
| Grant of Share Options | 07-Aug-2025 | 11:22 | RNS |
| IB Announces Soft Close to Phase 1 Trial | 21-Jul-2025 | 07:00 | RNS |
| Director/PDMR Dealing | 09-Jul-2025 | 17:14 | RNS |
| IB Provides Update on BTD Application | 12-Jun-2025 | 10:30 | RNS |
| Change of Name | 27-May-2025 | 07:00 | RNS |
| Result of AGM | 22-May-2025 | 14:23 | RNS |
| Application: FDA Breakthrough Therapy Designation | 02-May-2025 | 07:29 | RNS |
| Currency | UK Pounds |
| Share Price | 0.90p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 1.90 |
| 52 Week Low | 0.60 |
| Volume | 3,319,130 |
| Shares Issued | 246.71m |
| Market Cap | £2.22m |
| Beta | 0.40 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:13 | 1 @ 0.85p |
| 15:13 | 4,978 @ 0.85p |
| 15:13 | 140 @ 0.95p |
| 15:13 | 999 @ 0.85p |
| 15:13 | 49 @ 0.85p |
You are here: research